Recent estimates suggest that 40 to 65 percent of acute bacterial infections can be traced back to biofilms. Accordingly, Dr. Cole discusses the use of emerging imaging modalities and notes that adjunctive therapies that can target and disrupt biofilms may provide a viable complement to thorough debridement.